10 clinical biostatistics experts
Clinical biostatistics leadership inside drug developers is the common thread here, from a head of biostatistics at Denali Therapeutics and a former one at Actinium Pharmaceuticals to program and therapeutic area statistics leads at Novartis, Pfizer and CSL. One spent 14 years as a statistical reviewer at FDA. Their records suit a sponsor deciding how to build a biostatistics function, plan a pivotal trial's statistics, or prepare for regulatory questions on an analysis.
Professionals to explore
Jennifer Ng
LinkedInExperience: Director, Biostatistics and Global Program Biostatistics Head · Novartis
$606 per 30-minute call
As Director, Biostatistics and Global Program Biostatistics Head at Novartis since 2021, Jennifer Ng sets strategic direction and quantitative decision making for global clinical development programs and has managed teams of statisticians, programmers and data managers. Jennifer Ng was Associate Director Scientific Staff at Novartis (2005-2017) and Associate Director, Biostatistics at Merck (1990-2005), a fit for program-level statistical strategy.
Is this you? Claim your profile and get paid for calls.
Jenny Huang
LinkedInExperience: Executive Director, Biostatistics · Gilead Sciences
$673 per 30-minute call
Oncology filings are Jenny Huang's focus as Executive Director, Biostatistics at Gilead Sciences since 2021, leading biostatistics support for oncology molecules in clinical trials through filing and label negotiation. Jenny Huang was Head of Biometrics at Forty Seven Inc. (2016-2020) and Group Leader, Genentech Biostatistics at Roche (2008-2016), so they can compare biometrics work at Forty Seven Inc., Genentech and Gilead Sciences.
Is this you? Claim your profile and get paid for calls.
Junxiang Luo
LinkedInExperience: Former Sr. Director of Biostatistics · Moderna
$740 per 30-minute call
Junxiang Luo has been Director II of Biostatistics at AbbVie since 2025 and was Sr. Director of Biostatistics at Moderna (2021-2025) and Director, Biostatistics at Sanofi (2018-2021). Their experience covers clinical trial design, statistical analysis, NDA/BLA submission and regulatory interaction across rare diseases, cardiovascular, diabetes and immunology, which makes Junxiang Luo a fit for submission and regulatory response questions.
Is this you? Claim your profile and get paid for calls.
Kate Li
LinkedInExperience: Executive Director, Head of Biostatistics · Actinium Pharmaceuticals, Inc.
$539 per 30-minute call
Kate Li spent 14 years as a statistical reviewer at FDA and has been Senior Director at Novartis since 2025. Kate Li was Executive Director, Head of Biometrics at Novartis (Anthos Therapeutics) (2024-2025), Executive Director, Head of Biostatistics at Actinium Pharmaceuticals, Inc. (2023-2024) and Executive Director at PTC Therapeutics, Inc. (2022-2023), the strongest fit for questions on how FDA statisticians read a submission.
Is this you? Claim your profile and get paid for calls.
Lingling Li
LinkedInExperience: Executive Director, Biostatistics · Alexion Pharmaceuticals, Inc.
$606 per 30-minute call
Lingling Li has been Executive Director, Biostatistics at Alexion Pharmaceuticals, Inc. since 2025 and was VP, Biostatistics at Acrivon Therapeutics, Inc. (2024-2025), Vice President of Biometrics at ImmunoGen, Inc. (2022-2024) and AVP, Head of Biostatistics and Statistical Programming at Karyopharm Therapeutics Inc. (2020-2022). Their experience runs from early-phase dose optimization to registration-enabling studies, a fit for dose-finding questions.
Is this you? Claim your profile and get paid for calls.
Ran Li
LinkedInExperience: Former Director Biostatistics · Astellas Pharma
$471 per 30-minute call
At Astellas Pharma, Ran Li has held five biostatistics titles: Senior Director of Biostatistics since 2026, Director Biostatistics (2023-2026), Associate Director Biostatistics (2020-2023), Senior Manager Biostatistics (2018-2020) and Manager Biostatistics (2017-2018). In the director role Ran Li managed a team of five statisticians focused on gastrointestinal programs, so they can speak to running a therapeutic area statistics team.
Is this you? Claim your profile and get paid for calls.
Yanyan Li
LinkedInExperience: Former Director, Global Therapeutic Area Lead Statistician · CSL
$505 per 30-minute call
Hematology is Yanyan Li's area at CSL: Senior Director, Hematology Statistics Lead since 2026 and Director, Global Therapeutic Area Lead Statistician (2020-2025), after Associate Director, Biostatistics (2017-2020). Yanyan Li has managed statistical teams of direct reports, contractors and CROs and has worked across hematology, CNS and pain, respiratory, oncology and women's health, useful for questions on managing CRO statisticians.
Is this you? Claim your profile and get paid for calls.
Yiyi Chen
LinkedInExperience: Director of Biostatistics · Pfizer
$539 per 30-minute call
Academia appears in Yiyi Chen's record: Associate professor at Oregon Health and Science University, Knight Cancer Institute (2015-2021). Yiyi Chen has been Director of Biostatistics at Pfizer since 2025, serving as global statistical lead for a clinical program, and held Associate Director and Principal Biostatistician roles at Seagen (2021-2024), a fit for questions on oncology trial statistics and moving from academia into industry.
Is this you? Claim your profile and get paid for calls.
Yuda Zhu
LinkedInExperience: Executive Director, Head of Biostatistics · Denali Therapeutics
$606 per 30-minute call
At Denali Therapeutics, Yuda Zhu has been Executive Director, Head of Biostatistics since 2025 and was Senior Director, Head of Biostatistics (2021-2025), Director, Biostatistics (2019-2021) and Principal Biostatistician (2017-2019). Yuda Zhu was Senior Statistical Scientist - Nonclinical at Genentech (2012-2017), so building a biostatistics group as a biotech grows is the natural topic.
Is this you? Claim your profile and get paid for calls.
Ziliang Li
LinkedInExperience: Director Biostatistics · CRISPR Therapeutics
$505 per 30-minute call
Ziliang Li has been Director Biostatistics at CRISPR Therapeutics since 2021, serving as biostatistics lead on the cross-functional team that designs and runs the clinical development plan, Phase 1 to 3 studies and non-interventional work such as real-world evidence and biomarker studies. Ziliang Li held Associate Director Biostatistics and Principal Biostatistician roles at Vertex Pharmaceuticals (2017-2021) and statistics roles at Merck (2010-2017).
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
If you are building or leading a statistics group at a smaller biotech, start with those who have headed the function: Yuda Zhu, Kate Li or Lingling Li. Global program and therapeutic area questions fit Jennifer Ng, Yiyi Chen and Yanyan Li, and Kate Li or Junxiang Luo are the better call when the question is about FDA review and submissions.
Questions to take into the conversation
- 01When should a biotech hire its own head of biostatistics instead of relying on a CRO's statisticians?
- 02How do you choose an estimand and primary analysis for a pivotal trial that regulators will accept?
- 03What statistical questions come up most often in label negotiation after a filing?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.